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ABSTRACT
Lithium has been known to be an effective medication for people with bipolar disorder. The mechanisms
of action of lithium in the brain is not very well understood. NMR spectroscopy and imaging are effective
both in determining lithium levels in tissue and brain. We have monitored lithium levels in red blood cells.
We have been able to separate intra- and extracellular compartments oflithium using shift reagents, thereby
obtaining T1's of both the compartments. Lithium uptake as a function of hematocrit was monitored weekly over a 3 week period. The time constant of 50 mM lithium uptake at 25 °C and 85% hematocrit was
found to be 16.5 hrs. The time constant of 1.8 mM lithium uptake at 37 °C and 45% hematocrit was
found to be 1 1 .6 hrs. Experiments on the visibility of the quadrupolar nuclei indicate that itis only 74-90%
visible and the visibility decreased with decreasing concentrations.
INTRODUCTION
Lithium salts have been used with considerable success in treating
both depressive and manic recurrences of bipolar illnesses. Despite much
research, little is known concerning the mechanism ofaction (Stern and
Lydiard, 1987). We and others have detected in vivo 'LiNMR signals
from the brains of both rats and humans on lithium therapy (Komorosk i
et al., 1989; Renshaw and Wicklund, 1988). It is important to know
the intra- to extracellular ratio in the brain and, hence, the origin of
the in vivo 7 LiNMR signals, because the presumed site ofaction is intracellular in the brain. A simple model where intra- to extracellular
ratios of lithium have been determined and lithium transport studied
is the red blood cell (Pettegrew et al., 1987; Espanol, et al., 1987; Hughes
et al., 1988; Mota de Freitas et al., 1988). Apparently conflicting results
concerning the 7LiNMR visibility of intracellular lithium have been
reported (Pettegrew etal, 1987; Hughes etal., 1988). We report studies
of lithium transport across erythrocyte membranes, spin-lattice relaxation times, and NMR visibility at low concentrations of lithium.
MATERIALSAND METHODS
Lithium-7 spectra were acquired at 116.8 MHz ona General Electric
GN-300 FT NMR spectrometer using 10 or 20 mm O.D. sample tubes.
Spin-lattice relaxation times (T,) were measured using the inversionrecovery technique. Dysprosium tripolyphosphate was the extracellular
shift reagent. A typical spectrum showing intra and extra peak separation is shown in Figure 1 after incubating red blood cells with lithium
for 24 hours. One pint of fresh venous blood was drawn into citrate
dextrose anticoagulant (CPDA-1) and typically was used in 1-2 days.
Blood obtained from the (JAMS Blood Bank was examined up to one
month later. Erythrocytes were spun down and washed in a buffer containing 150 mM NaCl according topublished methods (Espanol et al.,
1987).

RESULTS AND DISCUSSION
We obtained a 7Li T, of 5.7 s for intracellular lithium at 25 °C, a
value comparable to that previously reported (Espanol et al., 1987).
For packed erythrocytes at 25 °C, the extracellular T, was 6.5 s, substan-

tially shorter than the 16.5 s reported previously at 13% hematocrit
(Espanol et al., 1987). At37 °C the intra- and extracellular T, values
are increased to 6.5 and 8.2 s, respectively. This latter value is reduced
from the expected value of about 22 s, which we found for pure NMR
buffer (see Table 1). The two-component behavior of the T, curves will
not be a suitable method for distinguishing these compartments inthe
human brain in vivo because the intra- and extracellular T,s are not
greatly

different.

Figure 1. Intra- and Extra-Cellular
Dysprosium Tripolyphosphate

Components
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Table 1. Spin Lattice (T,) Relaxation Times of Various Solutions.

@25°C

1M LiCl
3.5 mM LiCl

Extracellular Li(RBC)
Intracellular Li(RBC)

13.0 sees.
13.0 sees.
6.5 sees
5.7 sees

<o)37 0C

1MLiCl
50 mM LiCl
NMR Buffer
Extracellular Li(RBC)
Intracellular Li(RBC)
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23.0 sees.
20.3 sees.
22.0 sees.
8.2 sees.
6.5 sees.
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As expected, the percentage of intracellular lithium decreases with
decreasing hematocrit. The percentage of intracellular lithium increased substantially (100 - 200%) with aging from one to three weeks
(see Figure 2). We have measured the kinetics of lithium transport into
the cells for two situations. At50 mM lithium (25 °C) and about 85%
hematocrit (packed cells), we obtained a time constant of 16.5 hours,
close to the 14.7 hours found by Pettegrew et al., (1987). We first
detected lithium about one-half hour into the experiment (see Figure
3). The kinetic data for 1.8 mM lithium at a level of 45% hemotocrit
and 37 °C are shown in Figure 4. These conditions closely approximate
those expected clinically. The time constant was 11.6 hours. Inthis case,
intracellular lithium was first observed 1.5 hours into the experiment.
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Figure 4. Kinetics of Li(1.8 mM) Transport in Red Blood Cells (45%
Hematocrit) at 37 °C
Table 2. NMR 'Visibility'of Lithium in Erythrocytes
Cone, of

% Total Visibility

Figure 2. Li Uptake as a Function of Hematocrit

% Intracellular
*

Visibility

LiCL
40 mM

87.5

74.0

10 mM

80.0

70.0

5 mM

78.0

66.0

74J)

63J)

1 mM

*assuming

allthe invisibilityis due to intracellular

compartment.
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Figure 3. Kinetics of Li(50 mM) Transport in Packed Red Blood Cells
at25°C
Spin-3/2 nuclei can exhibit reduced "NMR visibility"in motionally
restricted environments (Bull, 1972). Such is common for "Na but, in
this regard, little is known about 7Li. Pettegrew et al. (1987) reported
98% visibility for the total signal from packed erythrocytes with about
33% intracellular lithium at 50 mM LiCl, whereas Hughes et al. (1988)
reported fullextracellular but reduced intracellular visibility at 40 mM
LiCl. This reduced visibility is attributed to the binding of lithium to
cell membrane and other cellular components.
We have examined the visibilityof 7Li at several concentrations for
packed red cells. At 40 mM, we found a total visibility of 88-90%,
whereas at 1 to 10 mM, visibility was reduced to 74 to 84% (see Table
2). Our experiments do not permit separate determination ofintra- and
extracellular visibility. These results suggest that 7Lisignals detection
in vivosuffer from reduced visibility of one or both components.
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